A prospective study of measured body size and height and risk of keratinocyte cancers and melanoma

Cancer Epidemiology

Volumn 40, Issue , 2016, Pages 119-125

  Lahmann, Petra H ^a,b   Hughes, Maria Celia B ^a   Williams, Gail M ^c   Green, Adèle C ^a,d  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

BMI; BSA; Epidemiology; Height; Longitudinal study; Melanoma; Skin cancer

Indexed keywords

ADULT; ARTICLE; BASAL CELL CARCINOMA; BODY HEIGHT; BODY SIZE; BODY SURFACE; BODY WEIGHT; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MELANOMA SKIN CANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; AGED; AUSTRALIA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; INCIDENCE; KERATINOCYTE; MELANOMA; MIDDLE AGED; PATHOLOGY; PHENOTYPE; QUEENSLAND; SELF REPORT; SKIN NEOPLASMS;

ADULT; AGED; AUSTRALIA; BODY HEIGHT; BODY SIZE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; INCIDENCE; KERATINOCYTES; MALE; MELANOMA; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; QUEENSLAND; RISK FACTORS; SELF REPORT; SKIN NEOPLASMS;

EID: 84960105062     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.12.006     Document Type: Article

References (50)

1. Fransen M., Karahalios A., Sharma N., English D.R., Giles G.G., Sinclair R.D. Non-melanoma skin cancer in Australia. Med. J. Aust. 2012, 197:565-568.
2. Lomas A., Leonardi-Bee J., Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br. J. Dermatol. 2012, 166:1069-1080.
3. Erdmann F., Lortet-Tieulent J., Schuz J., Zeeb H., Greinert R., Breitbart E.W., et al. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk?. Int. J. Cancer 2013, 132:385-400.
4. Diepgen T.L., Mahler V. The epidemiology of skin cancer. Br. J. Dermatol. 2002, 146(Suppl. 61):1-6.
5. Holman C.D., Armstrong B.K., Heenan P.J. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J. Nat. Cancer Inst. 1983, 71:651-656.
6. Madan V., Lear J.T., Szeimies R.M. Non-melanoma skin cancer. Lancet 2010, 375:673-685.
7. WCRF-AICR Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective 2007, World Cancer Research Fund/American Institute for Cancer Research.
8. Bhaskaran K., Douglas I., Forbes H., dos-Santos-Silva I., Leon D.A., Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 2014, 384:755-765.
9. Renehan A.G., Tyson M., Egger M., Heller R.F., Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578.
10. Sergentanis T.N., Antoniadis A.G., Gogas H.J., Antonopoulos C.N., Adami H.O., Ekbom A., et al. Obesity and risk of malignant melanoma: a meta-analysis of cohort and case-control studies. Eur. J. Cancer 2013, 49:642-657.
11. Gerstenblith M.R., Rajaraman P., Khaykin E., Doody M.M., Alexander B.H., Linet M.S., et al. Basal cell carcinoma and anthropometric factors in the U.S. radiologic technologists cohort study. Int. J. Cancer 2012, 131:E149-E155.
12. Pothiawala S., Qureshi A.A., Li Y., Han J. Obesity and the incidence of skin cancer in US Caucasians. Cancer Causes Control. 2012, 23:717-726.
13. Praestegaard C., Kjaer S.K., Christensen J., Tjonneland A., Halkjaer J., Jensen A. Obesity and risks for malignant melanoma and non-melanoma skin cancer: results from a large danish prospective cohort study. J. Invest. Dermatol. 2015, 135:901-904.
14. Olsen C.M., Hughes M.C., Pandeya N., Green A.C. Anthropometric measures in relation to basal cell carcinoma: a longitudinal study. BMC Cancer 2006, 6:82.
15. Nagel G., Bjorge T., Stocks T., Manjer J., Hallmans G., Edlinger M., et al. Metabolic risk factors and skin cancer in the metabolic syndrome and cancer project (Me-Can). Br. J. Dermatol. 2012, 167:59-67.
16. Tang J.Y., Henderson M.T., Hernandez-Boussard T., Kubo J., Desai M., Sims S.T., et al. Lower skin cancer risk in women with higher body mass index: the women's health initiative observational study. Cancer Epidemiol. Biomarkers Prev. 2013, 22:2412-2415.
17. Wiren S., Haggstrom C., Ulmer H., Manjer J., Bjorge T., Nagel G., et al. Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control. 2014, 25:151-159.
18. Thune I., Olsen A., Albrektsen G., Tretli S. Cutaneous malignant melanoma: association with height, weight and body-surface area. a prospective study in Norway. Int. J. Cancer 1993, 55:555-561.
19. Olsen C.M., Green A.C., Zens M.S., Stukel T.A., Bataille V., Berwick M., et al. Anthropometric factors and risk of melanoma in women: a pooled analysis. Int. J. Cancer 2008, 122:1100-1108.
20. Green J., Cairns B.J., Casabonne D., Wright F.L., Reeves G., Beral V. Height and cancer incidence in the million women study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol. 2011, 12:785-794.
21. Kabat G.C., Kim M.Y., Hollenbeck A.R., Rohan T.E. Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP diet and health study. Cancer Causes Control CCC 2014, 25:1697-1706.
22. Kabat G.C., Anderson M.L., Heo M., Hosgood H.D., Kamensky V., Bea J.W., et al. Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol. Biomarkers Prev. 2013, 22:1353-1363.
23. Kabat G.C., Heo M., Kamensky V., Miller A.B., Rohan T.E. Adult height in relation to risk of cancer in a cohort of Canadian women. Int. J. Cancer 2013, 132:1125-1132.
24. Kvaskoff M., Bijon A., Mesrine S., Vilier A., Clavel-Chapelon F., Boutron-Ruault M.C. Anthropometric features and cutaneous melanoma risk: a prospective cohort study in French women. Cancer Epidemiol. 2014, 38:357-363.
25. Green A., Beardmore G., Hart V., Leslie D., Marks R., Staines D. Skin cancer in a Queensland population. J. Am. Acad. Dermatol. 1988, 19:1045-1052.
26. Green A., Battistutta D., Hart V., Leslie D., Marks G., Williams G., et al. The nambour skin cancer and actinic eye disease prevention trial: design and baseline characteristics of participants. Control Clin. Trials 1994, 15:512-522.
27. Green A., Williams G., Neale R., Hart V., Leslie D., Parsons P., et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999, 354:723-729.
28. Lahmann P.H., Russell A., Green A.C. Prospective study of physical activity and risk of squamous cell carcinoma of the skin. BMC Cancer 2011, 11:516.
29. WHO Obesity preventing and managing the global epidemic: report of a WHO consultation. WHO Technical Report Series (894) 2000, World Health Organization, Geneva.
30. Mosteller R.D. Simplified calculation of body-surface area. N. Engl. J. Med. 1987, 317:1098.
31. Verbraecken J., Van de Heyning P., De Backer W., Van Gaal L. Body surface area in normal-weight, overweight, and obese adults. A comparison study. Metabolism 2006, 55:515-524.
32. Green A.C., Hughes M.C., McBride P., Fourtanier A. Factors associated with premature skin aging (photoaging) before the age of 55: a population-based study. Dermatology 2011, 222:74-80.
33. Richmond-Sinclair N.M., Pandeya N., Williams G.M., Neale R.E., van der Pols J.C., Green A.C. Clinical signs of photodamage are associated with basal cell carcinoma multiplicity and site: a 16-year longitudinal study. Int. J. Cancer 2010, 127:2622-2629.
34. Valery P.C., Neale R., Williams G., Pandeya N., Siller G., Green A. The effect of skin examination surveys on the incidence of basal cell carcinoma in a Queensland community sample: a 10-year longitudinal study. J. Invest. Dermatol. Symp. Proc. 2004, 9:148-151.
35. Green A.C., Williams G.M., Logan V., Strutton G.M. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J. Clin. Oncol. 2011, 29:257-263.
36. Zou G. A modified poisson regression approach to prospective studies with binary data. Am. J. Epidemiol. 2004, 159:702-706.
37. Dennis L.K., Lowe J.B., Lynch C.F., Alavanja M.C. Cutaneous melanoma and obesity in the Agricultural health study. Ann. Epidemiol. 2008, 18:214-221.
38. Albanes D., Jones D.Y., Schatzkin A., Micozzi M.S., Taylor P.R. Adult stature and risk of cancer. Cancer Res. 1988, 48:1658-1662.
39. Gunnell D., Okasha M., Smith G.D., Oliver S.E., Sandhu J., Holly J.M. Height, leg length, and cancer risk: a systematic review. Epidemiol. Rev. 2001, 23:313-342.
40. Renehan A.G. Height and cancer: consistent links, but mechanisms unclear. Lancet Oncol. 2011, 12:716-717.
41. Batty G.D., Shipley M.J., Gunnell D., Huxley R., Kivimaki M., Woodward M., et al. Height, wealth, and health: an overview with new data from three longitudinal studies. Econ. Hum. Biol. 2009, 7:137-152.
42. Wood A.R., Esko T., Yang J., Vedantam S., Pers T.H., Gustafsson S., et al. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 2014, 46:1173-1186.
43. Albanes D., Winick M. Are cell number and cell proliferation risk factors for cancer?. J. Natl. Cancer Inst. 1988, 80:772-774.
44. Trichopoulos D., Lipworth L. Is cancer causation simpler than we thought, but more intractable?. Epidemiology 1995, 6:347-349.
45. Clayton P.E., Banerjee I., Murray P.G., Renehan A.G. Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat. Rev. Endocrinol. 2011, 7:11-24.
46. Park S.L., Setiawan V.W., Kanetsky P.A., Zhang Z.F., Wilkens L.R., Kolonel L.N., et al. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels with risk of malignant melanoma. Cancer Causes Control. 2011, 22:1267-1275.
47. Antoniadis A.G., Petridou E.T., Antonopoulos C.N., Dessypris N., Panagopoulou P., Chamberland J.P., et al. Insulin resistance in relation to melanoma risk. Melanoma Res. 2011, 21:541-546.
48. Neale R., Williams G., Green A. Application patterns among participants randomized to daily sunscreen use in a skin cancer prevention trial. Arch. Dermatol. 2002, 138:1319-1325.
49. Green A.C., Williams G.M. Point sunscreen use is a safe and effective approach to skin cancer prevention. Cancer Epidemiol. Biomarkers Prev. 2007, 16:1921-1922.
50. Ribero S., Glass D., Aviv A., Spector T.D., Bataille V. Height and bone mineral density are associated with naevus count supporting the importance of growth in melanoma susceptibility. PLoS One 2015, 10:e0116863.